Enbrel 50 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F3G2Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,240
Award facts
- Contract value 100% obligated
- $13,239.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 22, 2026, for Enbrel 50 mg/ml syringes valued at $13,239.67. The order is non-competitive and carries a firm fixed price structure with an ultimate completion date of January 23, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, an expansive $999,999,999 vehicle through December 31, 2031, that serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare programs globally.
The Defense Logistics Agency procures pharmaceutical and medical commodities for the Department of Defense's Medical Supply Chain, which serves military treatment facilities and veterans' healthcare systems. Enbrel (etanercept) is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions, representing the type of specialty pharmaceutical products Cencora supplies through its federal contracts. As a child entity of Cencora, Inc., AmerisourceBergen Drug Corp maintains critical infrastructure for pharmaceutical distribution and continues to demonstrate its capability to fulfill federal medical supply requirements through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26F3G2Y?
SPE2DR26F3G2Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F3G2Y worth?
The government has obligated $13,240 on SPE2DR26F3G2Y.
Is contract SPE2DR26F3G2Y an order under another contract?
Yes. SPE2DR26F3G2Y is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3G2Y competed?
The extent of competition for SPE2DR26F3G2Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award